Market Share of Global Migraine Therapeutics Industry
The migraine therapeutics market is moderately fragmented with the presence of a large number of local and international players. Key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key market players include Amgen, Teva Pharmaceutical, Eli Lilly and Company, and GlaxoSmithKline plc, among others.
Migraine Therapeutics Market Leaders
Amgen
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Eli Lilly and Company
Bausch Health
*Disclaimer: Major Players sorted in no particular order